Medifast Inc
MED11.398USD
-0.452-3.81%
Market hours （ET）Quotes delayed by 15 min
125.28MMarket Cap
498.16P/E TTM
More Details of Medifast Inc Company
Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. It sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.
Medifast Inc Info
Ticker SymbolMED
Company nameMedifast Inc
IPO dateDec 30, 1993
CEOChard (Daniel R)
Number of employees504
Security typeOrdinary Share
Fiscal year-endDec 30
Address100 International Drive, 18th Floor
CityBALTIMORE
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code21202
Phone14105818042
Websitehttps://medifastinc.com/
Ticker SymbolMED
IPO dateDec 30, 1993
CEOChard (Daniel R)
Company Executives of Medifast Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
164.95K
-39.55%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.02K
+86.92%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
13.91K
+12.00%
Mr. Michael A. Hoer
Mr. Michael A. Hoer
Independent Director
Independent Director
--
--
Ms. Claudia C. Greninger
Ms. Claudia C. Greninger
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Jonathan B. Mackenzie
Mr. Jonathan B. Mackenzie
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
--
--
Mr. Jeffrey J. Brown
Mr. Jeffrey J. Brown
Lead Independent Director
Lead Independent Director
--
--
Mr. Anthony E. Tyree
Mr. Anthony E. Tyree
Chief Marketing Officer, Chief Business Operations
Chief Marketing Officer, Chief Business Operations
--
--
Mr. Ming Xian
Mr. Ming Xian
Independent Director
Independent Director
--
--
Ms. Elizabeth A. Geary
Ms. Elizabeth A. Geary
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
164.95K
-39.55%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.02K
+86.92%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
13.91K
+12.00%
Mr. Michael A. Hoer
Mr. Michael A. Hoer
Independent Director
Independent Director
--
--
Ms. Claudia C. Greninger
Ms. Claudia C. Greninger
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Jonathan B. Mackenzie
Mr. Jonathan B. Mackenzie
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
--
--
Revenue Breakdown
FY2025Q2
FY2025Q1
FY2024
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
105.56M
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Tue, Nov 18
Updated: Tue, Nov 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
7.62%
Renaissance Technologies LLC
7.29%
The Vanguard Group, Inc.
6.47%
Charles Schwab Investment Management, Inc.
5.42%
BofA Global Research (US)
4.12%
Other
69.09%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
7.62%
Renaissance Technologies LLC
7.29%
The Vanguard Group, Inc.
6.47%
Charles Schwab Investment Management, Inc.
5.42%
BofA Global Research (US)
4.12%
Other
69.09%
Shareholder Types
Shareholders
Proportion
Investment Advisor
34.59%
Investment Advisor/Hedge Fund
25.52%
Hedge Fund
17.51%
Research Firm
7.05%
Individual Investor
3.30%
Family Office
0.88%
Pension Fund
0.13%
Bank and Trust
0.12%
Insurance Company
0.03%
Other
10.85%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
470
8.80M
80.10%
-3.51M
2025Q2
501
8.65M
78.71%
-4.63M
2025Q1
543
8.84M
80.44%
-4.55M
2024Q4
558
9.50M
86.82%
-4.11M
2024Q3
566
9.73M
88.98%
-4.84M
2024Q2
601
11.02M
100.79%
-3.10M
2024Q1
608
12.20M
111.59%
-579.67K
2023Q4
629
10.91M
100.15%
-1.24M
2023Q3
641
10.20M
93.63%
-1.89M
2023Q2
664
10.18M
93.46%
-1.94M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
799.27K
7.27%
-56.13K
-6.56%
Jun 30, 2025
Renaissance Technologies LLC
813.31K
7.4%
-75.62K
-8.51%
Jun 30, 2025
The Vanguard Group, Inc.
795.45K
7.24%
+31.89K
+4.18%
Jun 30, 2025
Charles Schwab Investment Management, Inc.
421.17K
3.83%
+155.60K
+58.59%
Jun 30, 2025
BofA Global Research (US)
396.37K
3.61%
+107.85K
+37.38%
Jun 30, 2025
Two Sigma Investments, LP
419.02K
3.81%
-16.70K
-3.83%
Jun 30, 2025
Acadian Asset Management LLC
411.10K
3.74%
+25.38K
+6.58%
Jun 30, 2025
Parametric Portfolio Associates LLC
323.67K
2.94%
+108.94K
+50.73%
Jun 30, 2025
AQR Capital Management, LLC
220.13K
2%
+20.38K
+10.20%
Jun 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Acquirers Small and Micro Deep Value ETF
0.79%
Federated Hermes MDT Small Cap Core ETF
0.19%
First Trust Active Factor Small Cap ETF
0.15%
iShares US Small Cap Value Factor ETF
0.15%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.12%
Schwab Fundamental U.S. Small Company ETF
0.06%
iShares US Small-Cap Equity Factor ETF
0.04%
Franklin US Small Cap Multifactor Index ETF
0.02%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
View more
Acquirers Small and Micro Deep Value ETF
Proportion0.79%
Federated Hermes MDT Small Cap Core ETF
Proportion0.19%
First Trust Active Factor Small Cap ETF
Proportion0.15%
iShares US Small Cap Value Factor ETF
Proportion0.15%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proportion0.12%
Schwab Fundamental U.S. Small Company ETF
Proportion0.06%
iShares US Small-Cap Equity Factor ETF
Proportion0.04%
Franklin US Small Cap Multifactor Index ETF
Proportion0.02%
iShares Micro-Cap ETF
Proportion0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.02%
Dividend
A total of
262.40M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Sep 07, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on Nov 07, 2023 going ex on Sep 18, 2023
Sep 19, 2023
Nov 07, 2023
Sep 18, 2023
Jun 15, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on Aug 08, 2023 going ex on Jun 26, 2023
Jun 27, 2023
Aug 08, 2023
Jun 26, 2023
Mar 16, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on May 09, 2023 going ex on Mar 27, 2023
Mar 28, 2023
May 09, 2023
Mar 27, 2023
Dec 08, 2022
MED.NB Final Cash Dividend of gross USD 1.64 paid on Feb 07, 2023 going ex on Dec 19, 2022
Dec 20, 2022
Feb 07, 2023
Dec 19, 2022
Sep 08, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on Nov 08, 2022 going ex on Sep 19, 2022
Sep 20, 2022
Nov 08, 2022
Sep 19, 2022
Jun 16, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on Aug 08, 2022 going ex on Jun 27, 2022
Jun 28, 2022
Aug 08, 2022
Jun 27, 2022
Mar 17, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on May 09, 2022 going ex on Mar 28, 2022
Mar 29, 2022
May 09, 2022
Mar 28, 2022
Dec 08, 2021
MED.NB Final Cash Dividend of gross USD 1.42 paid on Feb 08, 2022 going ex on Dec 20, 2021
Dec 21, 2021
Feb 08, 2022
Dec 20, 2021
Sep 09, 2021
MED.NB Interim Cash Dividend of gross USD 1.42 paid on Nov 08, 2021 going ex on Sep 20, 2021
Sep 21, 2021
Nov 08, 2021
Sep 20, 2021
Jun 03, 2021
MED.NB Interim Cash Dividend of gross USD 1.42 paid on Aug 06, 2021 going ex on Jun 21, 2021
Jun 22, 2021
Aug 06, 2021
Jun 21, 2021
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Medifast Inc?
The top five shareholders of Medifast Inc are:
BlackRock Institutional Trust Company, N.A. holds 799.27K shares, accounting for 7.27% of the total shares.
Renaissance Technologies LLC holds 813.31K shares, accounting for 7.40% of the total shares.
The Vanguard Group, Inc. holds 795.45K shares, accounting for 7.24% of the total shares.
Charles Schwab Investment Management, Inc. holds 421.17K shares, accounting for 3.83% of the total shares.
BofA Global Research (US) holds 396.37K shares, accounting for 3.61% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 799.27K shares, accounting for 7.27% of the total shares.
Renaissance Technologies LLC holds 813.31K shares, accounting for 7.40% of the total shares.
The Vanguard Group, Inc. holds 795.45K shares, accounting for 7.24% of the total shares.
Charles Schwab Investment Management, Inc. holds 421.17K shares, accounting for 3.83% of the total shares.
BofA Global Research (US) holds 396.37K shares, accounting for 3.61% of the total shares.
What are the top three shareholder types of Medifast Inc?
The top three shareholder types of Medifast Inc are:
BlackRock Institutional Trust Company, N.A.
Renaissance Technologies LLC
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Renaissance Technologies LLC
The Vanguard Group, Inc.
How many institutions hold shares of Medifast Inc (MED)?
As of 2025Q3, 470 institutions hold shares of Medifast Inc, with a combined market value of approximately 8.80M, accounting for 80.10% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 1.39%.
What is the biggest source of revenue for Medifast Inc?
In FY2025Q2, the -- business generated the highest revenue for Medifast Inc, amounting to -- and accounting for --% of total revenue.
